SC 13D/A

GKCC, LLC ELICIO THERAPEUTICS, INC SCHEDULE 13D/A

Company: Elicio Therapeutics, Inc.
Filed: July 2, 2024
Accession Number: 0001068238-24-000141

View Document ↗ View on SEC.gov ↗